Evaluation of risk factors for the development of bacteremia and complications in patients with brucellosis: Is it possible to predict the clinical course?


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
30 09 2023
Historique:
received: 04 03 2023
accepted: 28 04 2023
medline: 1 11 2023
pubmed: 12 10 2023
entrez: 12 10 2023
Statut: epublish

Résumé

Brucellosis is often confused with other diseases or accompanies the conditions it imitates. It causes treatment delays, failure, relapse, and complications. This study aimed to investigate bacteremia and complication predictors in Brucellosis patients. Early detection may help reduce relapse rates, length of hospital stay, and surgical intervention rates by providing appropriate treatment. We examined 220 adult patients diagnosed with Brucellosis in our tertiary care hospital in the Black Sea Region between January 01, 2010, and January 01, 2022. Patients with and without bacteremia and complications were compared regarding demographic characteristics, clinical features, and laboratory parameters. The mean age was 46.4 ± 15.8 years (18-96 years), and 61% were male. Low back pain and absence of muscle pain were independent risk factors for predicting bacteremia (p = 0.049, p = 0.043, respectively). Weakness /fatigue, weight loss, and 1/320 Standard Tube Agglutination Test (STAT) or Brucella Coombs Gel Test (BCGT) titers were independent risk factors that reduced the risk of complications; in contrast, low back pain and splenomegaly were independent risk factors for development of complications. (p = 0.025, p = 0.007, p = 0.008, p = 0.003, p = 0.021 respectively). Thrombocytopenia was related to complications. When the platelet cut-off value was taken as 160,000/µL in predicting complications, the sensitivity was 31.30%, and the specificity was 97.73% (p = 0.011). The risk of clinical progression and complications could be predicted with symptoms and signs such as myalgia, low back pain, weakness/fatigue, weight loss, splenomegaly, and easily accessible laboratory parameters such as serum STAT/BCGT titer and platelet level.

Identifiants

pubmed: 37824349
doi: 10.3855/jidc.18164
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1277-1284

Informations de copyright

Copyright (c) 2023 Tuba Kuruoglu, Levent Sensoy, Aynur Atilla, Fatih Temocin, Demet Gur, Esra Tanyel.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Tuba Kuruoglu (T)

Department of Clinical Microbiology and Infectious Disease, Faculty of Medicine Ondokuz Mayis University, Samsun, Turkiye.

Levent Sensoy (L)

Department of Clinical Microbiology and Infectious Disease, Faculty of Medicine Ondokuz Mayis University, Samsun, Turkiye.

Aynur Atilla (A)

Department of Clinical Microbiology and Infectious Disease, Faculty of Medicine Ondokuz Mayis University, Samsun, Turkiye.

Fatih Temocin (F)

Department of Clinical Microbiology and Infectious Disease, Faculty of Medicine Ondokuz Mayis University, Samsun, Turkiye.

Demet Gur (D)

Department of Medical Microbiology, Faculty of Medicine Ondokuz Mayis University, Samsun, Turkiye.

Esra Tanyel (E)

Department of Clinical Microbiology and Infectious Disease, Faculty of Medicine Ondokuz Mayis University, Samsun, Turkiye.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH